ResMed, Inc. (RMD) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $210.98 +1.16%
Revenue Growth %: +13.1%
Financial Fact:
Diluted earnings per share (note 2-j): 0.54
Today's EPS Names:
HFBL, PBHC, PBNK, More
Revenue Growth %: +13.1%
Financial Fact:
Diluted earnings per share (note 2-j): 0.54
Today's EPS Names:
HFBL, PBHC, PBNK, More
Join SI Premium – FREE
ResMed, Inc. (NYSE: RMD) reported Q2 EPS of $0.53, $0.02 better than the analyst estimate of $0.51. Revenue for the quarter came in at $376.5 million versus the consensus estimate of $363.76 million.
For earnings history and earnings-related data on ResMed, Inc. (RMD) click here.
For earnings history and earnings-related data on ResMed, Inc. (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Investing.com’s stocks of the week
- Pathfinder Bancorp (PBHC) Tops Q2 EPS by 42c
- Contineum Therapeutics, Inc. (CTNM) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
